Top Page
Extendicare
(TSX:EXE)
Extendicare (EXE) vs. iShares MSCI Canada ETF (EWC)
Extendicare Business Overview & Revenue Model
Extendicare Earnings Call Summary
Extendicare Financial Statement Overview
| Breakdown | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 1.47B | 1.30B | 1.22B | 1.17B | 1.10B |
| Gross Profit | 168.00M | 167.62M | 76.83M | 115.61M | 201.16M |
| EBITDA | 152.52M | 98.63M | 48.90M | 67.46M | 125.08M |
| Net Income | 75.21M | 33.98M | 69.55M | 11.50M | 54.19M |
Balance Sheet | |||||
| Total Assets | 719.79M | 672.73M | 781.58M | 900.32M | 963.13M |
| Cash, Cash Equivalents and Short-Term Investments | 121.85M | 75.91M | 167.28M | 104.63M | 179.96M |
| Total Debt | 292.49M | 334.52M | 383.97M | 536.85M | 564.60M |
| Total Liabilities | 595.44M | 584.81M | 680.88M | 798.40M | 834.94M |
| Stockholders Equity | 124.35M | 87.92M | 100.70M | 101.92M | 128.19M |
Cash Flow | |||||
| Free Cash Flow | 101.69M | -106.13M | -2.76M | -6.10M | 88.17M |
| Operating Cash Flow | 143.64M | 23.28M | 98.87M | 59.08M | 121.27M |
| Investing Cash Flow | -9.11M | -84.45M | 155.64M | -59.39M | 2.00M |
| Financing Cash Flow | -87.87M | -30.93M | -191.86M | -74.84M | -38.16M |
Extendicare Technical Analysis
Extendicare Peers Comparison
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
68 Neutral | C$1.68B | 42.93 | 6.93% | 5.19% | 8.76% | 14.05% | |
68 Neutral | C$1.05B | 13.70 | 71.61% | 4.04% | 9.38% | 117.85% | |
62 Neutral | C$1.19B | 30.45 | -3.53% | ― | 17.19% | -191.01% | |
61 Neutral | C$183.22M | ― | -4.48% | ― | -0.69% | 8.08% | |
46 Neutral | C$201.68M | -3.23 | -23.14% | 1.87% | 20.75% | -0.36% | |
| ― | $207.58M | 2.32 | 33.87% | 2.35% | ― | ― | |
| ― | $189.99M | ― | ― | ― | ― |
Extendicare Corporate Events
Extendicare Inc. has declared a cash dividend of C$0.042 per common share for July 2025, payable on August 15, 2025, to shareholders of record as of July 31, 2025. This announcement reflects the company’s ongoing commitment to returning value to its shareholders, reinforcing its stable financial position and dedication to maintaining investor confidence.
The most recent analyst rating on (TSE:EXE) stock is a Hold with a C$11.00 price target. To see the full list of analyst forecasts on Extendicare stock, see the TSE:EXE Stock Forecast page.
Extendicare Inc. announced the release of its second quarter 2025 financial results scheduled for August 6, 2025, followed by a conference call on August 7, 2025, led by its top executives. This announcement is part of Extendicare’s ongoing communication strategy with stakeholders, reflecting its commitment to transparency and engagement in the senior care industry.
The most recent analyst rating on (TSE:EXE) stock is a Hold with a C$11.00 price target. To see the full list of analyst forecasts on Extendicare stock, see the TSE:EXE Stock Forecast page.
Extendicare has completed the acquisition of Closing the Gap Healthcare Group through its subsidiary ParaMed Inc., enhancing its capabilities in rehabilitation services and integrated care models. This acquisition, valued at $75.5 million with potential earnouts, is expected to strengthen Extendicare’s home healthcare platform. Additionally, Extendicare has increased its Senior Secured Credit Facility to $375 million, positioning itself for further strategic acquisitions and growth, supported by a $100 million increase in its credit facilities.
The most recent analyst rating on (TSE:EXE) stock is a Hold with a C$11.00 price target. To see the full list of analyst forecasts on Extendicare stock, see the TSE:EXE Stock Forecast page.
Extendicare Inc. has announced a cash dividend of C$0.042 per common share for June 2025, payable on July 15, 2025, to shareholders recorded by June 30, 2025. This move reflects the company’s ongoing commitment to providing returns to its investors while maintaining its focus on delivering quality care services to Canada’s growing senior population. The announcement may positively impact shareholder value and reinforce Extendicare’s position in the senior care industry.
The most recent analyst rating on (TSE:EXE) stock is a Hold with a C$11.00 price target. To see the full list of analyst forecasts on Extendicare stock, see the TSE:EXE Stock Forecast page.
Extendicare Inc. has completed the acquisition of nine ‘Class C’ long-term care homes from Revera Inc. in Ontario and Manitoba, along with a parcel of vacant land in Ontario, for approximately $60.3 million. This strategic acquisition, funded by cash on hand, expands Extendicare’s footprint in the senior care industry, enhancing its capacity to provide quality care to a growing senior population. The transaction underscores Extendicare’s commitment to meeting the increasing demand for senior care services and strengthens its market position in Canada.
The most recent analyst rating on (TSE:EXE) stock is a Hold with a C$11.00 price target. To see the full list of analyst forecasts on Extendicare stock, see the TSE:EXE Stock Forecast page.
Extendicare Inc. announced the results of its 2025 Annual and Special Meeting of Shareholders, where key decisions included the election of nine directors, the appointment of KPMG LLP as auditors, approval of unallocated entitlements under the Long Term Incentive Plan, and acceptance of the company’s approach to executive compensation. These decisions reflect strong shareholder support and are expected to reinforce Extendicare’s strategic direction and operational stability, impacting its positioning in the senior care industry and providing assurance to stakeholders about the company’s governance and financial oversight.
The most recent analyst rating on (TSE:EXE) stock is a Hold with a C$11.00 price target. To see the full list of analyst forecasts on Extendicare stock, see the TSE:EXE Stock Forecast page.
Extendicare reported a strong first quarter in 2025, with a 42.7% increase in adjusted EBITDA to $29.0 million, driven by growth across all business segments. The company announced a 5.0% dividend increase and significant expansion in its home health care segment. Extendicare completed the sale of three LTC projects, generating $56.3 million in cash proceeds, and is advancing its acquisition of Closing the Gap Healthcare Group, which will add substantial service hours to its operations. The company’s strategic focus on growth and redevelopment is evident in its ongoing projects and acquisitions, positioning it for continued expansion in the healthcare sector.
Extendicare Inc. announced that its subsidiary, ParaMed Inc., will acquire Closing the Gap Healthcare Group, a provider of integrated home and community-based healthcare services in Ontario and Nova Scotia. The acquisition, valued at approximately $75.5 million, is expected to close in the third quarter of 2025 and will be funded from cash on hand and existing credit facilities. This strategic move is anticipated to enhance Extendicare’s home health care operations, adding significant service volumes and revenue, while also generating cost synergies through the integration of back-office functions.